GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer

NCT05419362 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: GEN-001
DRUG: Avelumab

Sponsor

Genome & Company

Collaborators

[object Object]